var quiz = [
   
   
    {
        q: `<!--1. -->The effects of administration of an antimuscarinic agent to an individual with an overactive bladder (OAB) include all of the following EXCEPT:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->increased total bladder capacity.`, 
        `<!--b. -->depressed amplitude of involuntary bladder contractions.`, 
        `<!--c. -->increased outlet resistance.`, 
        `<!--d. -->increased volume to the first involuntary bladder contraction. `, 
        `<!--e. -->increased mean volume voided. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: `Rationale: <b>Atropine and atropine-like agents will depress normal bladder contractions and involuntary bladder contractions of any cause.</b> In such patients, the volume to the first involuntary bladder contraction will generally be increased, the amplitude of the involuntary bladder contraction decreased, and the total bladder capacity increased. Outlet resistance, at least as reflected by urethral pressure measurements, does not seem to be clinically affected.`,
        state: `notAnswered`,
        userAnswered: []
      ,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`        ,
        type: `MCSS`},
      {
        q: `<!--2. -->Which of the following muscarinic receptor subtypes is the most common in human detrusor smooth muscle?`,
        q2: ``,
        q3: [],
        option: [`M<sub>1</sub>`, 
        `M<sub>2</sub>`, 
        `M<sub>3</sub>`, 
        ` M<sub>4</sub>`, 
        `M<sub>5</sub> `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [1],
        ansText: `Rationale: On the basis of existing knowledge, it is now recommended that the designations M<sub>1</sub> to M<sub>5</sub> be used to describe both the pharmacologic subtypes and the molecular subtypes of muscarinic acetylcholine receptors. <b>The human urinary bladder smooth muscle contains a mixed population of M<sub>2</sub> and M<sub>3</sub> subtypes, with M<sub>2</sub> receptors predominant (M<sub>2</sub> receptors predominate at least 3:1 versus M<sub>3</sub> receptors not only on detrusor cells but also on other bladder structures, which may be of importance for detrusor activation).</b>`,
        state: `notAnswered`,
        userAnswered: []
      ,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`        ,
        type: `MCSS`},
      {
        q: `<!--3. -->Which of the following muscarinic receptor subtypes is predominantly responsible for the mediation of bladder contraction in human detrusor smooth muscle?`,
        q2: ``,
        q3: [],
        option: [`M<sub>1</sub>`, 
        `M<sub>2</sub>`, 
        `M<sub>3</sub>`, 
        `M<sub>4</sub> `, 
        `M<sub>5</sub> `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: `Rationale: <b>The minor population of M<sub>3</sub> receptors is generally accepted at this time as primarily responsible for the mediation of bladder contraction.</b>`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--4. -->The use of antimuscarinic agents to treat OAB is limited by their lack of uroselectivity. Which of the following is NOT a recognized side effect of antimuscarinic agents?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->Dry mouth`, 
        `<!--b. -->Constipation`, 
        `<!--c. -->Cognitive dysfunction`, 
        `<!--d. -->Bradycardia `, 
        `<!--e. -->Blurred vision `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: `Rationale: In general, drug therapy for lower urinary tract dysfunction is hindered by a concept that can be expressed in one word: uroselectivity. <b>The clinical utility of available antimuscarinic agents is limited by their lack of selectivity, responsible for the classic peripheral antimuscarinic side effects of dry mouth, constipation, blurred vision, tachycardia, and effects on cognitive function.</b>`,
        state: `notAnswered`,
        userAnswered: []
      ,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`        ,
        type: `MCSS`},
      {
        q: `<!--5. -->Which of the following characteristics increases the possibility for an antimuscarinic agent to pass the blood-brain barrier?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->High lipophilicity`, 
        `<!--b. -->Large molecular size`, 
        `<!--c. -->Low electrical charge`, 
        `<!--d. -->Quaternary ammonium structure `, 
        `<!--e. -->Small molecular size `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
      ,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`        ,
        type: `MCSS`},
      {
        q: `<!--6. -->Anticholinergics exert their favorable effects on OAB by affecting:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->peripheral afferent (sensory) transmission.`, 
        `<!--b. -->ganglionic transmission.`, 
        `<!--c. -->central neural afferent transmission.`, 
        `<!--d. -->muscarinic receptors on the detrusor smooth muscle. `, 
        `<!--e. -->nicotinic receptors on the detrusor smooth muscle. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--7. -->The Committee on Pharmacologic Treatment of the Fifth (2013) International Consultation on Incontinence assessed agents according to the Oxford Guideline, according to level of evidence and grade of recommendation with respect to treatment of detrusor overactivity (DO). Which of the following (multiple answers are possible) did NOT receive a level of evidence rating of 1 and a grade of recommendation of A?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->Fesoterodine`, 
        `Flavoxate`, 
        `Trospium`, 
        `Solifenacin `, 
        `Oxybutynin `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [1],
        ansText: `Rationale: A level of 1 implies the presence of systematic reviews, meta-analysis, and good-quality randomized controlled clinical trials. A grade of recommendation of A means that the agent is highly recommended based on level 1 evidence. Flavoxate received a level of evidence of 2, meaning that either randomized control trials and/or good-quality prospective cohort studies existed regarding its use, but a grade of recommendation of D, meaning that no recommendation for use is possible because of inconsistent/inconclusive evidence.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--8. -->Which of the following is NOT a class effect of antimuscarinics?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->Accommodation paralysis`, 
        `Constipation`, 
        `Increased heart rate`, 
        `Prolongation of the QT interval `, 
        `Dry mouth `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: `Rationale: Well-known peripheral antimuscarinic side effects include blurred vision due to accommodation paralysis, constipation due to impaired bowel motility, increase in heart rate due to some blockade of M<sub>2</sub> cardiac receptors, and dry mouth due primarily to blockade of M<sub>3</sub> receptors in the salivary glands. QT prolongation is not related to muscarinic blockade but rather linked to inhibition of the hERG potassium channel in the heart. Some antimuscarinic drugs may in fact cause this, but this is not a class effect.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--9. -->Of the following choices, which are correct? The bladder contains how many β-receptor subtypes (answer 1) _______ with the (answer 2) _______ having the most important functional role.`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->one; β<sub>2</sub>`, 
        `<!--b. -->two; β<sub>2</sub>`, 
        `<!--c. -->three; β<sub>3</sub>`, 
        `<!--d. -->four; β<sub>2</sub> `, 
        `<!--e. -->five; β<sub>5</sub> `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: `Rationale: Three cloned subtypes of β-adrenergic receptors, β<sub>1</sub>, β<sub>2</sub>, β<sub>3</sub>, have been identified in the detrusor of most species, including humans. Studies have revealed a predominant expression of the β<sub>3</sub> receptor, and there is functional evidence for an important role in both normal and neurogenic bladders. The β<sub>3</sub> agonist mirabegron represents the first drug in this class to be developed for treatment of OAB.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--10. -->Which of the following pharmacologic actions is most likely responsible for the effects of oxybutynin when given systemically?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->Antimuscarinic, direct muscle relaxant, and local anesthetic actions, equally`, 
        `<!--b. -->Direct muscle relaxant effect alone`, 
        `<!--c. -->Direct muscle relaxant effect and local anesthetic action`, 
        `<!--d. -->Antimuscarinic and direct muscle relaxant effects `, 
        `<!--e. -->Antimuscarinic effect `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: Oxybutynin has several pharmacologic effects, some of which seem difficult to relate to its effectiveness in the treatment of DO. It has antimuscarinic, direct muscle relaxant, and local anesthetic actions. The local anesthetic action and direct muscle relaxant effect may be of importance when the drug is administered intravesically but probably play no role when it is given orally. In vitro, oxybutynin was shown to be 500 times weaker as a smooth muscle relaxant than as an antimuscarinic agent. Most probably, when given systematically, oxybutynin acts mainly as an antimuscarinic drug.`,
        state: `notAnswered`,
        userAnswered: []
      ,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`        ,
        type: `MCSS`},
      {
        q: `<!--11. -->Which of the following muscarinic receptor subtypes are NOT known to be involved in the potential antimuscarinic side effects of dry mouth, constipation, tachycardia, drowsiness, and blurred vision?`,
        q2: ``,
        q3: [],
        option: [`M<sub>1</sub>`, 
        `M<sub>2</sub>`, 
        `M<sub>3</sub>`, 
        `M<sub>4</sub> `, 
        `M<sub>5</sub> `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--12. -->The primary adverse event reported with the use of oxybutynin-transdermal has been:`,
        q2: ``,
        q3: [],
        option: [`tachycardia.`, 
        `dry mouth.`, 
        `constipation.`, 
        `application site reactions. `, 
        `blurred vision. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: `Rationale: The transdermal delivery of oxybutynin alters oxybutynin metabolism, reducing production of the primary metabolite, responsible for most of the side effects, to an even greater extent than extended-release oxybutynin. The primary adverse event for this preparation has been application-site reaction: pruritus in 14% and erythema in 8.3%.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--13. -->Which of the following agents is relatively selective for M<sub>3</sub> receptor blockade?`,
        q2: ``,
        q3: [],
        option: [`Darifenacin`, 
        `Oxybutynin`, 
        `Solifenacin`, 
        `Tolterodine `, 
        `Trospium `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0],
        ansText: `Rationale: Darifenacin is relatively selective for M<sub>3</sub> receptor blockade, meaning that, in vitro, the affinity for M<sub>3</sub> receptors is greater than for the other muscarinic receptors. This is only a relative selectivity, however, and whether this translates into either greater efficacy or greater tolerability has yet to be established.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--14. -->Mirabegron probably exerts its favorable effect on OAB by:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->activating the β<sub>3</sub> adrenergic receptor`, 
        `<!--b. -->competitive blockade of the β<sub>3</sub> receptor.`, 
        `<!--c. -->inhibiting filling-induced activity in bladder afferent nerves.`, 
        `<!--d. -->activating the α-adrenergic receptor. `, 
        `<!--e. -->inhibiting the α-adrenergic receptor. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--15. -->Of the following agents, which is actively excreted by the kidney in the proximal convoluted tubules?`,
        q2: ``,
        q3: [],
        option: [`Darifenacin`, 
        `Oxybutynin`, 
        `Solifenacin`, 
        `Tolterodine `, 
        `Trospium `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: Darifenacin, oxybutynin, solifenacin, and tolterodine are all actively metabolized in the liver by the cytochrome P450 enzyme system. Trospium chloride is not metabolized to any significant degree in the liver. It is actively excreted by the proximal convoluted tubules in the kidney.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--16. -->Which is (are) TRUE about tadalafil?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->It improves International Index of Erectile Function (IIEF) scores.`, 
        `<!--b. -->It improves International Prostate Symptom Score (IPSS) scores.`, 
        `<!--c. -->It improves peak flow rates.`, 
        ` <!--d. -->It is approved for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO).`, 
        `<!--e. -->It decreases detrusor pressure at peak flow. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--17. -->Which of the following is NOT listed as a common side effect of imipramine?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->Systemic antimuscarinic effects`, 
        `<!--b. -->Weakness, fatigue`, 
        `<!--c. -->Priapism`, 
        `<!--d. -->Cardiac arrhythmia `, 
        `<!--e. -->Hepatic dysfunction `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: `Rationale: <b>The most frequent side effects of the tricyclic antidepressants are those attributable to their systemic antimuscarinic activity.</b> Allergic phenomena (including rash), hepatic dysfunction, obstructive jaundice, and agranulocytosis may also occur, but rarely. Central nervous system side effects may include weakness, fatigue, parkinsonian effect, fine tremor noted most in the upper extremities, manic or schizophrenic picture, and sedation, probably from an antihistaminic effect. Postural hypotension may also be seen, presumably on the basis of selective blockade (a paradoxic effect) of α<sub>1</sub>-adrenergic receptors in some vascular smooth muscle. Tricyclic antidepressants can also cause excess sweating of obscure cause and a delay of orgasm or orgasmic impotence, the cause of which is likewise unclear. They can also produce arrhythmias and interact in deleterious ways with other drugs, and so caution must be observed in their use in patients with cardiac disease. They have not been reported to cause priapism.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--18. -->In men with BPO and OAB, adding an antimuscarinic to an α-adrenergic blocking agent will:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->significantly increase residual urine volume.`, 
        `<!--b. -->significantly decrease detrusor pressure at peak flow.`, 
        `<!--c. -->significantly decrease peak and mean flow rate.`, 
        `<!--d. -->cause a, b, and c. `, 
        `<!--e. -->none of the above. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: <b>Several randomized control trials have demonstrated that the combination treatment of antimuscarinic drugs and α<sub>1</sub>-adrenergic receptor antagonist is more effective at reducing male lower urinary tract symptoms than α-blockers alone in men with BPO and OAB.</b> Used in the recommended doses, and in men whose voiding was not significantly compromised previously, none of the parameters related to emptying changed appreciably (detrusor pressures, flow rates, residual voided volume).`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--19. -->Intravesical botulinum toxin subtype A:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->activates synaptosomal-associated protein (SNAP) 25 and the soluble N-ethylmaleimide-sensitive factor attachment <i>protein</i> (SNARE) complex.`, 
        `<!--b. -->acts only on smooth muscle.`, 
        `<!--c. -->inhibits the peripheral release of acetylcholine.`, 
        `<!--d. -->is effective only in patients with both OAB and DO. `, 
        `<!--e. -->reduces firing from bladder afferents. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--20. -->Vaginal estrogen is effective in the treatment of:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->urogenital atrophy.`, 
        `<!--b. -->stress urinary incontinence (SUI).`, 
        `<!--c. -->urgency urinary incontinence.`, 
        `<!--d. -->mixed urinary incontinence. `, 
        `<!--e. -->anterior vaginal prolapse. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0],
        ansText: `Rationale: <b>The evidence supporting the use of estrogens in lower urinary tract dysfunction remains controversial, but considerable data support the use of vaginal estrogen in urogenital atrophy. The vaginal route improves dryness, pruritus, and dyspareunia and provides a greater improvement in physical findings than oral administration.</b>`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--21. -->The side effects of the alpha-adrenergic agonists include all of the following EXCEPT:`,
        q2: ``,
        q3: [],
        option: [`tremor.`, 
        `palpitations.`, 
        `hypertension.`, 
        `somnolence. `, 
        `respiratory difficulties. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: `Rationale: Potential side effects of all of these agents include blood pressure elevation, anxiety, and insomnia due to stimulation of the central nervous system; headache; tremor; weakness; palpations; cardiac arrhythmias; and respiratory difficulties. They should be used with caution in patients with hypertension, cardiovascular disease, or hyperthyroidism.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--22. -->Which of the following has been reported to increase stroke risk in women younger than 50 years?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->Phenylpropanolamine`, 
        `Ephedrine`, 
        `Pseudoephedrine`, 
        `Midodrine `, 
        `Clenbuterol `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0],
        ansText: `Rationale: The risk of hemorrhagic stroke in women younger than 50 years has been reported to be 16 times higher in those who have been taking phenylpropanolamine, an α-adrenergic agonist, as an appetite suppressant, and 3 times higher in women who have been taking the drug for less than 24 hours as a cold remedy, although the latter was not statistically significant (the former was). Phenylpropanolamine has been removed from the market in the United States.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--23. -->In theory, which of the following agents, from the standpoint of potential efficacy and safety, would be preferred for the treatment of SUI in a hypertensive individual?`,
        q2: ``,
        q3: [],
        option: [`Ephedrine`, 
        `Propranolol`, 
        `Phenylpropanolamine`, 
        ` Pseudoephedrine`, 
        `Clenbuterol `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [1],
        ansText: `Rationale: Theoretically, β-adrenergic blocking agents, such as propranolol, might be expected to “unmask” or potentiate an α-adrenergic effect, thereby increasing urethral resistance. Such treatment has been suggested as an alternative treatment to α-adrenergic agonists in patients with sphincteric incontinence and hypertension. Some studies support such usage, but they are not randomized or controlled. The other compounds listed are α-adrenergic agonists and are a risk factor for increased blood pressure.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--24. -->Which of the following statements is NOT true with respect to duloxetine hydrochloride?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->It significantly increases sphincteric muscle activity during filling/storage in an animal model.`, 
        `<!--b. -->It is a serotonin-norepinephrine reuptake inhibitor.`, 
        `<!--c. -->It is lipophilic and well absorbed.`, 
        `<!--d. -->It is effective in decreasing SUI episodes in women. `, 
        `<!--e. -->It is not metabolized by the liver. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: Duloxetine hydrochloride is a serotonin-norepinephrine reuptake inhibitor that has been shown, in an animal model, to significantly increase urethral sphincteric muscle activity during the filling/storage phase of micturition. It is lipophilic, well absorbed, and extensively metabolized by the liver. It is still approved as a treatment for SUI in some countries. It was withdrawn from the FDA approval process in the United States but is licensed in the European Union for the treatment of SUI in women with moderate to severe incontinence, defined as 15 or more episodes per week.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--25. -->Oral estrogen with or without progesterones in postmenopausal women:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->improves mixed urinary incontinence.`, 
        `<!--b. -->worsens the risk of incontinence.`, 
        `<!--c. -->worsens urinary incontinence in women with incontinence.`, 
        `<!--d. -->improves SUI. `, 
        `<!--e. -->improves urgency incontinence. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [1],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--26. -->A 75-year-old man placed on desmopressin therapy 3 days previously presents with a change of mental status and mental confusion. The most likely cause is:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->cognitive dysfunction due to antimuscarinic effect.`, 
        `<!--b. -->hyponatremia.`, 
        `hypernatremia.`, 
        `hypokalemia. `, 
        `hyperkalemia. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [1],
        ansText: `Rationale: <b>Side effects are relatively uncommon during desmopressin treatment, but there is a risk of water retention and hyponatremia. It is recommended that serum sodium concentration be measured in elderly patients before and after a few days of treatment.</b>`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--27. -->With regard to bethanechol chloride, the least objective evidence exists to support which of the following statements?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->It has relatively selective in vitro action on urinary bladder and bowel.`, 
        `<!--b. -->It has little or no nicotinic action.`, 
        `<!--c. -->It is cholinesterase resistant.`, 
        `<!--d. -->It causes in vitro contraction of bladder and smooth muscle. `, 
        `<!--e. -->It facilitates bladder emptying. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: <b>Many acetylcholine-like drugs exist, but only bethanechol chloride (Urecholine, Duvoid, others) exhibits a relatively selective in vitro action on the urinary bladder and gut with little or no nicotinic action.</b> Bethanechol chloride is cholinesterase resistant and causes an in vitro contraction of smooth muscle from all areas of the bladder. Although it has been reported to increase gastrointestinal motility and has been used in the treatment of gastroesophageal reflux, and although anecdotal success in specific patients with voiding dysfunction seems to occur, there is no evidence to support its success in facilitating bladder emptying in a series of patients when the drug was the only variable.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--28. -->What oral dose of bethanechol chloride is required to produce the same urodynamic effects, at least in a denervated bladder, at the subcutaneous dose of 5 mg?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->200 mg`, 
        `<!--a. -->100 mg`, 
        `<!--a. -->50 mg`, 
        ` <!--a. -->25 mg`, 
        `<!--a. -->10 mg `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0],
        ansText: `Rationale: It is generally agreed that, at least in a “denervated” bladder, an oral dose of 200 mg is required to produce the same urodynamic effects as a subcutaneous dose of 5 mg.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--29. -->Prostaglandins have been hypothesized to affect bladder activity through all of the following actions EXCEPT:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->neuromodulation of efferent and afferent neurotransmission.`, 
        `<!--b. -->sensitization to sensory stimuli (activation occurs with a lower degree of filling).`, 
        `<!--c. -->activation of certain sensory nerves.`, 
        `<!--d. -->potentiation of acetylcholine release from cholinergic nerve terminals. `, 
        `<!--e. -->potentiation of adenosine triphosphate release from bladder mucosa. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: Prostanoids are synthesized both locally in bladder muscle and mucosa, with synthesis initiated by various physiologic stimuli such as detrusor muscle stretch, mucosal injury, and neural stimulation; directly by adenosine triphosphate; and by mediators of inflammation. Prostanoids have been variably reported to be useful in facilitating bladder emptying with intravesical administration. Possible roles include (1) neuromodulators of efferent and afferent transmission; (2) sensitization; (3) activation of certain sensory nerves; and (4) potentiation of acetylcholine (but not ATP) release from cholinergic nerve terminals through prejunctional prostanoid receptors.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--30. -->With respect to α- and β-adrenergic receptors in the lower urinary tract and prostate, all the following are true EXCEPT:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->α receptors outnumber β receptors in the smooth muscle of the bladder base and proximal urethra.`, 
        `<!--b. -->β receptors outnumber α receptors in the bladder body.`, 
        `<!--c. -->α<sub>1</sub> receptors are more common than α<sub>2</sub>.`, 
        `<!--d. -->Lower urinary tract and prostate adrenergically induced smooth muscle contraction is mediated largely by α<sub>1</sub> receptors. `, 
        `<!--e. -->Proximal urethral smooth muscle contraction is mediated primarily by α<sub>1</sub> receptors. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: `Rationale: <b>The human lower urinary tract contains more α<sub>2</sub> than α<sub>1</sub> receptors, but adrenergically induced human lower urinary tract smooth muscle contraction and prostate smooth muscle contraction are mediated largely, if not exclusively, by α<sub>1</sub> adrenergic receptors.</b> The remainder of the statements are true.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--31. -->Which of the following α-adrenergic blocking agents has significant antagonistic properties at both α<sub>1</sub> and α<sub>2</sub> receptor sites?`,
        q2: ``,
        q3: [],
        option: [`Prazosin`, 
        `Terazosin`, 
        `Phenoxybenzamine`, 
        `Doxazosin `, 
        `Tamsulosin `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: `Rationale: Phenoxybenzamine (Dibenzyline) was the α-adrenolytic agent originally used for the treatment of voiding dysfunction. It and phentolamine have blocking properties at both α-adrenergic receptor sites. Prazosin hydrochloride (Minipress) was the first potent selective α-adrenergic antagonist used to lower outlet resistance. <b>Terazosin (Hytrin) and doxazosin (Cardura) are two highly selective postsynaptic α<sub>1</sub>-adrenergic blockers. Most recently, alfuzosin and tamsulosin (Flomax), both highly selective α<sub>1</sub>-adrenergic blockers, have appeared and are marketed solely for the treatment of benign prostatic hyperplasia because of some reports suggesting preferential action on prostatic rather than vascular smooth muscle.</b>`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--32. -->Available data suggest that which of the following side effects is more common with tamsulosin than with either terazosin or doxazosin?`,
        q2: ``,
        q3: [],
        option: [`Dizziness`, 
        `Asthenia`, 
        `Postural hypotension`, 
        ` Palpitations`, 
        `Retrograde ejaculation `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: <b>Available data suggest that retrograde ejaculation and rhinitis are more common with tamsulosin, whereas dizziness and asthenia are more common with terazosin and doxazosin.</b>`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--33. -->Which of the following agents or classes of agents, when administered systemically, will selectively relax the striated musculature of the pelvic floor?`,
        q2: ``,
        q3: [],
        option: [`Benzodiazepines`, 
        `Dantrolene`, 
        `Baclofen`, 
        `Botulinum toxin `, 
        ` None of the above`,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: There is no class of pharmacologic agents that will selectively relax the striated musculature of the pelvic floor. Botulinum toxin-A when injected directly into the striated sphincter will relax it, but this “relative selectivity” is because of where it is locally injected.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--34. -->Which of the following is the most widely distributed inhibitory neurotransmitter in the mammalian central nervous system?`,
        q2: ``,
        q3: [],
        option: [`γ-Aminobutyric acid (GABA)`, 
        `Glycine`, 
        `Glutamate`, 
        `Dopamine `, 
        `Norepinephrine `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0],
        ansText: `Rationale: <b>GABA and glycine have been identified as major inhibitory transmitters in the central nervous system.</b> GABA is the most widely distributed inhibitory neurotransmitter in the mammalian central nervous system. It appears to mediate the inhibitory actions of local interneurons in the brain and presynaptic inhibition within the spinal cord.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--35. -->Baclofen (Lioresal) acts to decrease striated sphincter activity by which of the following mechanisms?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->Facilitating neuronal hyperpolarization through the GABA<sub>A</sub> receptor`, 
        `<!--b. -->Activating the GABA<sub>B</sub> receptor and depressing monosynaptic and polysynaptic excitation of motor neurons and interneurons in the spinal cord`, 
        `<!--c. -->Inhibiting excitation-contraction coupling in skeletal muscle by decreasing calcium release from the sarcoplasmic reticulum`, 
        `<!--d. -->Inhibiting excitation-contraction coupling by preventing calcium entry into the cell `, 
        `<!--e. -->Inhibiting acetylcholine release at the neuromuscular junction `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [1],
        ansText: `Rationale: Benzodiazepines potentiate the action of GABA by facilitating neuronal hyperpolarization through the GABA<sub>A</sub> receptor. Baclofen (Lioresal) depresses monosynaptic and polysynaptic excitation of motor neurons and interneurons in the spinal cord by activating GABA<sub>B</sub> receptors. Dantrolene (Dantrium) exerts its effects by a direct peripheral action on skeletal muscle. It is thought to inhibit the excitation-induced release of calcium ions from the sarcoplasmic reticulum of striated muscle fibers, thereby inhibiting excitation-contraction coupling and diminishing the mechanical force of contraction. Botulinum A toxin (Botox) is an inhibitor of acetylcholine release at the neuromuscular junction of somatic nerves on striated muscle.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--36. -->All of the following statements are true with regard to botulinum toxin EXCEPT:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->It has been reported to be useful in the treatment of striated sphincter dyssynergia via direct sphincteric injection.`, 
        `<!--b. -->It has been reported to be useful in the treatment of DO by direct intradetrusor injection.`, 
        `<!--c. -->It inhibits the release of acetylcholine and other transmitters at the neuromuscular junction of somatic nerve and striated muscle and the autonomic nerves in smooth muscle.`, 
        ` <!--d. -->It has been reported to be of use, via periurethral striated muscle injections, in the treatment of SUI.`, 
        `<!--e. -->The immunologic subtype utilized for urologic use has primarily been type A. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: `Rationale: Intrasphincteric injection of botulinum toxin A was first reported useful in the treatment of striated sphincteric dyssynergia in 1990. The toxin blocks the release of acetylcholine and other transmitters from presynaptic nerve endings by interacting with the protein complex necessary for docking vesicles. This results in decreased muscle contractility and muscle atrophy at the injection site. The drug has been reported to be of use as well in the treatment of neurogenic DO and cases of non-neurogenic DO. There are seven immunologically distinct antigenic subtypes. Types A and B are in clinical use in urology, but most studies and treatments have been carried out with botulinum toxin type A (Botox). Intrasphincteric injections of botulinum toxin are not useful for SUI. In fact, they can cause SUI in females.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--37. -->All of the following statements are true regarding the action of atropine and atropine-like agents (antimuscarinic agents) in patients with OAB and DO EXCEPT:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->Volume to first involuntary contraction increases.`, 
        `<!--b. -->Total bladder capacity increases.`, 
        `<!--c. -->Heart rate decreases.`, 
        ` <!--d. -->Urgency episodes decrease.`, 
        `<!--e. -->Amplitude of the DO contractions decreases. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: `Rationale: Those with an M<sub>2</sub> receptor blockade profile can increase heart rate, but the clinical significance of this is unknown.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--38. -->Which of the following statements is FALSE with respect to atropine resistance?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->It is secondary to release of norepinephrine from pelvic nerve in addition to acetylcholine.`, 
        `<!--b. -->It is of little importance in normal human detrusor function.`, 
        `<!--c. -->Its importance in treatment of DO in humans remains to be established.`, 
        `<!--d. -->It applies to the response of the whole bladder to pelvic nerve stimulation, but not to the response of the detrusor to exogenous cholinergic stimulation. `, 
        `<!--e. -->It is commonly invoked as a cause for only partial clinical improvement in the treatment of OAB with antimuscarinic agents. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0],
        ansText: `Rationale: The most common neurotransmitter mentioned as the prime alternate in atropine resistance is adenosine triphosphate. Norepinephrine is released by postganglionic sympathetic nerves (e.g., hypogastric), not by parasympathetic ones (e.g., pelvic).`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--39. -->Which statement is FALSE regarding M<sub>3</sub> receptors?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->They are less common than M<sub>2</sub> receptors in detrusor smooth muscle.`, 
        `<!--b. -->They are more common than M<sub>2</sub> receptors in urothelium.`, 
        `<!--c. -->They are the most important muscarinic receptor for detrusor contraction.`, 
        `<!--d. -->They are blocked by atropine. `, 
        ` <!--e. -->When activated, they lead to an increase in intracellular calcium in detrusor smooth muscle cells.`,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [1],
        ansText: `Rationale: M<sub>2</sub> receptors outnumber M<sub>3</sub> in urothelium as well as detrusor smooth muscle. All other statements are true.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--40. -->All of the following are well-known potential adverse events of antimuscarinic therapy EXCEPT:`,
        q2: ``,
        q3: [],
        option: [`constipation.`, 
        `cognitive dysfunction.`, 
        `increased heart rate.`, 
        `blurred vision. `, 
        `hyperhidrosis. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: If anything, antimuscarinic agents can cause decreased sweating. All the others are antimuscarinic side effects.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `Coming soon`,
        q2: ``,
        q3: [],
        option: [`Coming soon`],
        optionStyleType: `Coming soon`,
        answer: [`Coming soon`],
        ansText: `Rationale: Coming soon`,
        state: `notAnswered`,
        userAnswered: [`Coming soon`]
    },
      {
        q: `<!--42. -->When used in the usual dosages for the treatment of OAB in a patient who is not on clean intermittent catheterization, antimuscarinic agents act primarily by (more than one response may be correct):`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->reducing detrusor voiding contraction.`, 
        `<!--b. -->decreasing activity in C fibers.`, 
        `<!--c. -->decreasing activity in Aδ fibers.`, 
        ` <!--d. -->reducing the micromotions caused by the release of small packets of acetylcholine.`, 
        `<!--e. -->reducing excitation of afferent nerves from the urothelium and detrusor. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [1,2,3,4],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
      },
      {
        q: `<!--43. -->An 80-year-old man has OAB-wet and cognitive dysfunction. Theoretically, the antimuscarinic drug that would be expected to be the safest with respect to worsening his cognition is:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->solifenacin.`, 
        `<!--b. -->oxybutynin ER.`, 
        `<!--c. -->fesoterodine.`, 
        ` <!--d. -->trospium.`, 
        `tolterodine. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: `Rationale: Trospium, as a quaternary amine, is lipophobic and does not penetrate well through the blood-brain barrier. The others, all tertiary amines, do pass the blood-brain barrier to a greater extent.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--44. -->Activation of detrusor smooth muscle by both acetylcholine and adenosine triphosphate requires:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->increase in intracellular potassium concentration.`, 
        `<!--b. -->decrease in intracellular potassium concentration.`, 
        `<!--c. -->increase in intracellular calcium concentration.`, 
        ` <!--d. -->increase in intracellular cyclic guanosine monophosphate (GMP).`, 
        ` <!--e. -->increase in intracellular cyclic adenosine monophosphate (AMP).`,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: `Rationale: This occurs through both extracellular influx and mobilization of intracellular calcium.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--45. -->Which of the following have 1A or 1B ratings (modified Oxford system) for treatment of DO?`,
        q2: ``,
        q3: [],
        option: [`Flavoxate`, 
        `Dicyclomine`, 
        `Estrogen`, 
        `Tamsulosin `, 
        `Tolterodine `,
        `Fesoterodine`,
        `Darifenacin`,
        `Solifenacin`,
        `Propiverine`,
        `Oxybutynin`,
        `Trospium`
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4,5,6,7,8,9,10],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
      },
      {
        q: `<!--46. -->Which of the following drugs can produce or aggravate SUI in a woman?`,
        q2: ``,
        q3: [],
        option: [`Alfuzosin`, 
        `Nifedipine`, 
        `Tamsulosin`, 
        `Oxybutynin `, 
        `Propantheline `,
        `Flavoxate`,
        `Fesoterodine`,
        `Duloxetine`
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0,2],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
      },
      {
        q: `<!--47. -->Intravesical DMSO is:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->generally used in a 70% solution.`, 
        `<!--b. -->generally used in a 50% solution.`, 
        `<!--c. -->useful for the treatment of neurogenic DO.`, 
        ` <!--d. -->useful for the treatment of bladder pain syndrome (interstitial cystitis).`, 
        `<!--e. -->useful for the treatment of idiopathic DO. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [1,3],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
      },
      {
        q: `<!--48. -->Regarding the vanilloids, which of the following is/are TRUE?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->They act primarily to render C fibers insensitive.`, 
        `<!--b. -->They act primarily to render Aδ fibers insensitive.`, 
        `<!--c. -->When delivered intravesically, they cause a biphasic (excitation then blockade) effect.`, 
        `<!--d. -->Resiniferatoxin is much more potent than capsaicin for desensitization but proportionately less so for excitation. `, 
        `<!--e. -->Capsaicin is more potent than resiniferatoxin for desensitization. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0,2,3],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
      },
      {
        q: `<!--49. -->A 30-year-old paraplegic man is wet between intermittent catheterizations (catheterizes five times per day). He is on solifenacin, 10 mg daily, and reports moderate dry mouth and increased difficulty in his bowel regimen. A reasonable next step in treatment is to:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->increase dose of solifenacin.`, 
        `<!--b. -->add oxybutynin ER, 10 mg daily.`, 
        `<!--c. -->add darifenacin, 7.5 mg daily.`, 
        `<!--d. -->add darifenacin, 15 mg daily. `, 
        `<!--e. -->use intradetrusor botulinum toxin. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: Adding or increasing antimuscarinic medication will simply increase the severity of the adverse events already experienced. Intradetrusor botulinum toxin has been shown to be very effective in neurogenic DO and should be considered if following failure of, or intolerance to, antimuscarinic therapy.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      {
        q: `<!--50. -->Generally, treatment with intradetrusor botulinum toxin:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->must be repeated every 3 to 12 months.`, 
        `<!--b. -->improves quality of life in patients incontinent due to neurogenic DO.`, 
        `<!--c. -->loses efficacy with repeat treatments.`, 
        `<!--d. -->can cause urinary retention.`, 
        `<!--e. -->requires general anesthesia. `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0,1,3],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
      },
      {
        q: `<!--51. -->The Heart and Estrogen/Progestin Replacement Study (HERS), Women’s Health Initiative (WHI), and Nurses’ Health Study compositely showed that:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->oral estrogen plus progesterone worsened urinary incontinence in older postmenopausal women with incontinence.`, 
        `<!--b. -->oral estrogen plus progesterone increased the incidence of SUI and urgency urinary incontinence in those continent at baseline.`, 
        `<!--c. -->oral estrogen and progesterone worsened the frequency of incontinence in those incontinent at baseline.`, 
        `<!--d. -->transvaginal estrogen improves SUI in postmenopausal women. `, 
        ` <!--e. -->the risk of developing incontinence was increased in postmenopausal women taking estrogen alone or estrogen with progestin.`,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [0,1,2,4],
        ansText: ``,
        state: `notAnswered`,
        userAnswered: []
      },
      {
        q: `<!--52. -->Adrenergically induced smooth muscle contraction in the human lower urinary tract is mediated primarily by which receptor?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->α<sub>1D</sub>`, 
        `<!--b. -->β<sub>3</sub>`, 
        `<!--c. -->β<sub>2</sub>`, 
        `<!--d. -->α<sub>1A</sub> `, 
        `<!--e. -->α<sub>2</sub> `,
        ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: `Rationale: More α<sub>2</sub> than α<sub>1</sub> receptors are present, but adrenergically induced contraction is mediated largely by the α<sub>1A</sub> (and in the detrusor, α<sub>1D</sub>). β receptors cause smooth muscle relaxation. The β<sub>3</sub> subtype is the predominant β receptor in the human detrusor.`,
        state: `notAnswered`,
        userAnswered: []
              ,
        type: `MCSS`},
      
     
]